You say LinkedIn is inaccurate? So is the Q filed
Post# of 22456
Q stuff
The Company is also collaborating with a leading university in the medical field and intends to initially pursue the FDA EUA regulatory pathway while also pursuing the FDA 510(k) clearance of its test platform for non-Covid related testing. The Company also intends to pursue regulatory approvals in one or more foreign jurisdictions.
Notwithstanding the Trading Suspension and the revocation of the registration and termination of reporting status, the management continues to be dedicated to working on the development and commercialization of the Company’s QD enabled products and technologies with particular focus on point of care testing solutions, solar and anti-counterfeiting. We are also continuing our efforts on the deployment of our QMC HeathID App while its research and development team are fully engaged pushing the boundaries of our nano-materials.